http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2270014-C2
Outgoing Links
Predicate | Object |
---|---|
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
filingDate | 2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2006-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2c44f843eda600bd52d364c8c2932df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7b148ea446d32d7ce63d2e7d4630fbb |
publicationDate | 2006-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2270014-C2 |
titleOfInvention | Method for preventing complications during high-risk operations in small children at motor apparatus pathology and syndrome of increased thymus gland |
abstract | FIELD: medicine, pediatrics. n SUBSTANCE: in small children at syndrome of increased thymus gland degree 1-3 one should prescribe prednisolone and eubiotics simultaneously, and at degree 2-3 it is necessary to prescribe immunomodulating agents, additionally. The innovation provides increased anti-infectious immunity and inspecific body resistance due to efficient correction of hormonal state in this group of children. n EFFECT: higher efficiency of prophylaxis. n 2 cl, 1 ex |
priorityDate | 2004-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.